Bowie Kate R, Fischer Jared, Karstens Lisa
Department of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon, USA.
Cancer Early Detection Advanced Research (CEDAR), Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
bioRxiv. 2025 Feb 17:2025.02.13.638214. doi: 10.1101/2025.02.13.638214.
In the absence of infection, blood has previously been understood to be free of microbes. However, with advances in sequencing technology this notion has been challenged, prompting new investigations into microbial DNA within the blood of both healthy and diseased individuals. To comprehensively survey microbial DNA in blood, we separated blood into fractions (plasma, red blood cells, and buffy coat) and assessed if the microbial-DNA is cell-free by the addition of DNase to a subset of each fraction. We measured 16S rRNA gene copy number with digital droplet PCR and identified the taxonomic origin of the microbial DNA with synthetic full-length 16S rRNA gene sequencing. As a use case, we examine microbial DNA from the blood of 5 men without prostate cancer (PC), 5 men with low-grade PC, and 5 men with high-grade PC. Our study demonstrates that the majority of microbial DNA is cell-free, indicating that it is not representative of proliferating microbes. Our analyses also revealed buffy coat had the lowest number of 16S rRNA gene copies yet highest number of genera of the fractions (median 23.3 copies/μL and 10 genera) and thus may be a useful fraction to study moving forward. Additionally, microbial DNA in blood may have utility as a biomarker, as we detected disease-associated compositional differences in the plasma and buffy coat fractions. This study lays the groundwork for rigorously studying microbial DNA in blood, however larger studies are needed to confirm our disease-association findings.
在没有感染的情况下,血液以前被认为是不含微生物的。然而,随着测序技术的进步,这一观念受到了挑战,促使人们对健康个体和患病个体血液中的微生物DNA展开新的研究。为了全面检测血液中的微生物DNA,我们将血液分离成不同组分(血浆、红细胞和 Buffy 层),并通过向每个组分的一个子集添加 DNase 来评估微生物DNA是否为无细胞状态。我们使用数字液滴PCR测量16S rRNA基因拷贝数,并通过合成全长16S rRNA基因测序确定微生物DNA的分类学来源。作为一个应用案例,我们检测了5名无前列腺癌(PC)男性、5名低级别PC男性和5名高级别PC男性血液中的微生物DNA。我们的研究表明,大多数微生物DNA是无细胞的,这表明它不代表增殖的微生物。我们的分析还显示,Buffy层的16S rRNA基因拷贝数最少,但在各组分中属的数量最多(中位数为23.3拷贝/μL和10个属),因此可能是未来研究的一个有用组分。此外,血液中的微生物DNA可能具有作为生物标志物的效用,因为我们在血浆和Buffy层组分中检测到了与疾病相关的组成差异。这项研究为严格研究血液中的微生物DNA奠定了基础,不过还需要更大规模的研究来证实我们的疾病关联发现。